期刊文献+

化疗联合热疗治疗中晚期食管癌疗效观察 被引量:5

The perspective on efficacy of chemotherapy combined with hyperthermia treatment for advanced esophageal cancer
下载PDF
导出
摘要 目的探讨化疗联合热疗治疗中晚期食管癌的临床疗效。方法 51例中晚期食管癌患者,治疗组26例采用奥沙利铂+氟脲嘧啶方案化疗联合热疗,对照组25例单用化疗,比较2组近期疗效及毒副反应。结果化疗联合热疗组有效率(61.5%)高于单纯化疗治疗中晚期食管癌有效率(48.0%),差异有统计学意义(P<0.05),恶心呕吐、白细胞减少发生率低于对照组(P<0.05)。结论化疗联合热疗对中晚期食管癌有协同治疗作用且毒副反应较小。 Objective Investigate efficacy of chemotherapy combined with hyperthermia in advanced esophageal carcinoma.Methods 51 patients with advanced esophageal cancer patients were enrolled in test group and 26 patients treated with oxaliplatin+fluorouracil chemotherapy combined with hyperthermia,25 patients with advanced esophageal cancer patients were included in control group and treated with chemotherapy only,the efficacy and toxicity of 2 groups were compared.Results There are higher clinical treatment reponse and less toxicity in test group than that in control group(P0.05).Conclusion Chemotherapy combined with hyperthermia on advanced esophageal cancer may have synergistic effect and less toxicity.
出处 《新疆医科大学学报》 CAS 2010年第6期701-702,共2页 Journal of Xinjiang Medical University
关键词 食管癌 奥沙利铂 氟脲嘧啶 热疗 esophageal cancer oxaliplatin fluorouracil hyperthermia
  • 相关文献

参考文献5

二级参考文献25

  • 1李苏宜.食管癌内科治疗进展[J].实用临床医药杂志,2007,11(2):26-31. 被引量:2
  • 2Levard H, Pouliquen X, Hay JM, et al. 5-Fluorouracil and cisplatln as palliative treatment of advanced oesophageal squamous cell carcinoma.A multicentre randomised controlled trial. The French Associations for Surgical Besearch[J]. Eur J Surg, 1998, 164: 849- 857. 被引量:1
  • 3Spiridonidis CH, Laufman LR, Jones JJ, et at. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenoearcinoma[J ]. Cancer, 1996, 78:2070 -2077. 被引量:1
  • 4Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial [J].Jpn J Clin Oncol, 1992, 22: 172-176. 被引量:1
  • 5Zhang X, Shen L, Li J, et al. A phase II trial of paclltaxel and cisplatin in patients with advanced squamous--cell carcinoma of the esophagus[J]. Am J Clin Oncol, 2008, 31 (1): 29- 33. 被引量:1
  • 6Polee MB, Tilanus HW, Eskens FALM, et al. 1 Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patiems with a resectable squamous cell carcinoma of the esophagus [J]. Annals of Oncology, 2003, 14 (8) : 1253- 1257. 被引量:1
  • 7Syrigos KN, Zalonis A, Kotteas E, et al. Targeted therapy for oesophageal cancer: an overview[J]. Cancer Metastasis Rev,2008, 27 (2) : 273 - 288. 被引量:1
  • 8Tew WP, Kelsen DP, Ilson DH. Targeted therapies for esophageal cancer [J]. Oncologist, 2005,10(8) : 590 -601. 被引量:1
  • 9Pande AU, Iyer RV, Rani A, et al. Epidermal growth factor receptor - directed therapy in esophageal cancer [ J ]. Oncology, 2007, 73 (5 - 6) : 281 -289. 被引量:1
  • 10Dobelbower MC, Russo SM, Raisch KP, et al. Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5 - fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase Ⅰ study[ J]. Anticancer Drugs,2006, 17 ( 1 ) : 95 - 102. 被引量:1

共引文献8

同被引文献54

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部